
|Videos|March 9, 2022
Urology Times 50 Innovations Series: Active surveillance for prostate cancer
Author(s)Urology Times staff
"Active surveillance is an innovation because it's truly a departure from the idea that all prostate cancers or cancer, in general, needs to be treated," says Kara L. Watts, MD.
Advertisement
In this installment in Urology Times®' 50th Anniversary Innovation Celebration series, Kara L. Watts, MD, discusses the emergence and increasing uptake of active surveillance as a management strategy for men with prostate cancer. Watts, a member of the Urology Times® Editorial Council, is an assistant professor of urology at Montefiore Medical Center, Bronx, New York.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
2
Study launches of MRI plus PSMA-PET imaging for prostate cancer detection
3
Initial ARID results published in World Journal of Urology as pivotal trial progresses
4
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
5

























































